{"id":"placebo-matching-mifepristone","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Adrenal insufficiency risk"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mifepristone competitively antagonizes glucocorticoid receptors, preventing cortisol from exerting its downstream effects on the hypothalamic-pituitary-adrenal (HPA) axis and brain regions involved in fear conditioning and trauma memory consolidation. By blocking glucocorticoid signaling during or shortly after trauma exposure, it may reduce the formation or consolidation of traumatic memories and associated emotional responses. This mechanism has been investigated for prevention of post-traumatic stress disorder (PTSD) when administered in the acute post-trauma period.","oneSentence":"Mifepristone is a glucocorticoid receptor antagonist that blocks cortisol signaling to modulate stress-related memory and emotional processing.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:36:12.682Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of post-traumatic stress disorder (PTSD) in acute trauma survivors (investigational)"}]},"trialDetails":[{"nctId":"NCT02243709","phase":"PHASE1, PHASE2","title":"Mifepristone for the Prevention of Relapses of Alcohol Drinking","status":"COMPLETED","sponsor":"Brown University","startDate":"2014-09","conditions":"Alcohol Use Disorders (AUD)","enrollment":32},{"nctId":"NCT03052400","phase":"PHASE2","title":"Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus","status":"TERMINATED","sponsor":"Charles Drew University of Medicine and Science","startDate":"2017-02-03","conditions":"Type 2 Diabetes Mellitus, Insulin Resistance","enrollment":8},{"nctId":"NCT02412618","phase":"PHASE4","title":"Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2012-09","conditions":"Induced Abortion","enrollment":100},{"nctId":"NCT00698022","phase":"PHASE1","title":"A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2008-11","conditions":"Healthy","enrollment":76},{"nctId":"NCT02704481","phase":"PHASE4","title":"Non-surgical Alternatives to Treatment of Failed Medical Abortion","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2016-06-01","conditions":"Abortion Failure","enrollment":16},{"nctId":"NCT01419535","phase":"PHASE1, PHASE2","title":"Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2011-11-29","conditions":"Endocrine Disease, Diabetes","enrollment":19},{"nctId":"NCT03015701","phase":"PHASE3","title":"S9005 Mifepristone in Meningioma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1992-08","conditions":"Meningioma","enrollment":193},{"nctId":"NCT03508635","phase":"PHASE1","title":"CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2014-09","conditions":"Healthy","enrollment":130},{"nctId":"NCT03248713","phase":"EARLY_PHASE1","title":"Glucocorticoid Antagonist Treatment for Tobacco Use Disorder","status":"TERMINATED","sponsor":"Yale University","startDate":"2017-11-29","conditions":"Nicotine Dependence","enrollment":8},{"nctId":"NCT01212588","phase":"PHASE2","title":"Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)","status":"TERMINATED","sponsor":"Indiana University","startDate":"2010-09","conditions":"Borderline Personality Disorder","enrollment":22},{"nctId":"NCT01490697","phase":"PHASE4","title":"Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments","status":"COMPLETED","sponsor":"Roger K. Pitman, MD","startDate":"2009-03","conditions":"Post-traumatic Stress Disorder","enrollment":34},{"nctId":"NCT00680394","phase":"NA","title":"Comparing Two Regimens for Medical Abortion: Mifepristone+Misoprostol Versus Misoprostol Alone","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2007-07","conditions":"Pregnancy Termination","enrollment":440},{"nctId":"NCT00128479","phase":"PHASE3","title":"A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2004-09","conditions":"Major Depressive Disorder, Psychotic Disorders","enrollment":443},{"nctId":"NCT00146523","phase":"PHASE3","title":"An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2005-05","conditions":"Major Depressive Disorder","enrollment":247},{"nctId":"NCT00130676","phase":"PHASE3","title":"A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2004-09","conditions":"Major Depressive Disorder, Psychotic Disorders","enrollment":257}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo-matching Mifepristone","genericName":"Placebo-matching Mifepristone","companyName":"Roger K. Pitman, MD","companyId":"roger-k-pitman-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mifepristone is a glucocorticoid receptor antagonist that blocks cortisol signaling to modulate stress-related memory and emotional processing. Used for Prevention of post-traumatic stress disorder (PTSD) in acute trauma survivors (investigational).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}